chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Migraine
Clinical narrative: Migraine-like headache; This spontaneous case was reported by a consumer and describes the occurrence of MIGRAINE (Migraine-like headache) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included OMEPRAZOLE MAGNESIUM (PRILOSEC [OMEPRAZOLE MAGNESIUM]) for an unknown indication.   On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 05-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced MIGRAINE (Migraine-like headache). On 09-Apr-2021, MIGRAINE (Migraine-like headache) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No medical history provided. High Blood pressure concomitant medication mentioned but not provided.
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Injection site pain, Limb discomfort, Pyrexia
Clinical narrative: Got woozy; Fever; Pain on arm of injection; Cannot lift her arm; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (Cannot lift her arm), DIZZINESS (Got woozy), PYREXIA (Fever) and INJECTION SITE PAIN (Pain on arm of injection) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, the patient experienced LIMB DISCOMFORT (Cannot lift her arm) and INJECTION SITE PAIN (Pain on arm of injection). On an unknown date, the patient experienced DIZZINESS (Got woozy) and PYREXIA (Fever). At the time of the report, LIMB DISCOMFORT (Cannot lift her arm), DIZZINESS (Got woozy), PYREXIA (Fever) and INJECTION SITE PAIN (Pain on arm of injection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment included Ibuprofen.  Concomitant medicines include baby aspirin  Action taken with mRNA-1273 in response to the event was unknown   This case was linked to MOD21-075957 (Patient Link).
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Feeling abnormal, Vertigo
Clinical narrative: 2 days after second vaccination, he had his first episode with vertigo."; He feels like he is going to fall over; "When the vertigo is gone he is foggy, like brain fog."; This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (2 days after second vaccination, he had his first episode with vertigo."), DIZZINESS (He feels like he is going to fall over) and FEELING ABNORMAL ("When the vertigo is gone he is foggy, like brain fog.") in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Mar-2021, the patient experienced VERTIGO (2 days after second vaccination, he had his first episode with vertigo."), DIZZINESS (He feels like he is going to fall over) and FEELING ABNORMAL ("When the vertigo is gone he is foggy, like brain fog."). At the time of the report, VERTIGO (2 days after last vaccination, he had his last episode with vertigo."), DIZZINESS (He feels like he is going to fall over) and FEELING ABNORMAL ("When the vertigo is gone he is foggy, like brain fog.") outcome was unknown.            On 18 Feb 2021, the patient received first of two planned doses of mRNA-1273 for prophylaxis of COVID-19 infection. Concomitant Medications were not provided by the reporter. Patient stated doing exercises to release the crystal in the inner ear, Semont Maneuver to help relieve side effects. Action taken with mRNA-1273 in response to the events was not applicable.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Flushing, Pain in extremity, Peripheral swelling
Clinical narrative: Arm sore after 2nd dose; Arm swollen after 2nd dose; Face flushed after 2nd dose; Face red after 2nd dose; This spontaneous case was reported by a consumer and describes the occurrence of FLUSHING (Face flushed after 2nd dose), ERYTHEMA (Face red after 2nd dose), PAIN IN EXTREMITY (Arm sore after 2nd dose) and PERIPHERAL SWELLING (Arm swollen after 2nd dose) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046b21a) for COVID-19 vaccination.     Previously administered products included for an unreported indication: ACETAMINOPHEN (The patient  takes acetaminophen for pain regularly.) since an unknown date.   On 13-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Apr-2021, the patient experienced FLUSHING (Face flushed after 2nd dose) and ERYTHEMA (Face red after 2nd dose). On an unknown date, the patient experienced PAIN IN EXTREMITY (Arm sore after 2nd dose) and PERIPHERAL SWELLING (Arm swollen after 2nd dose). At the time of the report, FLUSHING (Face flushed after 2nd dose), ERYTHEMA (Face red after 2nd dose), PAIN IN EXTREMITY (Arm sore after 2nd dose) and PERIPHERAL SWELLING (Arm swollen after 2nd dose) outcome was unknown.            No concomitant medications reported. Treatment taken involved Acetaminophen for pain and Benadryl gel with camphor. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.
Age: 17.0
Sex: U
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: 17 year old who received the 1st dose of Moderna COVID-19; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 year old who received the 1st dose of Moderna COVID-19) in a 17-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 year old who received the 1st dose of Moderna COVID-19). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 year old who received the 1st dose of Moderna COVID-19) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. No treatment information was provided.   This case was linked to MOD21-063529 (E2B Linked Report).; Sender's Comments:  MOD21-063529:crosslink
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue, Vaccination site pain
Clinical narrative: Missed his due date for second dose of vaccine; Vaccination site pain; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Vaccination site pain) and PRODUCT DOSE OMISSION ISSUE (Missed his due date for second dose of vaccine) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination.     Concurrent medical conditions included Back pain (The patient's pre-existing medical condition includes back problem.) and Neck pain (The patient's pre-existing medical condition includes neck problem.).    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced VACCINATION SITE PAIN (Vaccination site pain). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Missed his due date for second dose of vaccine). At the time of the report, VACCINATION SITE PAIN (Vaccination site pain) outcome was unknown and PRODUCT DOSE OMISSION ISSUE (Missed his due date for second dose of vaccine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 03-Aug-2021: Non-Significant Follow up includes complete mailing address.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: Immediate swelling at the injection site after administering; This spontaneous case was reported by a physician and describes the occurrence of VACCINATION SITE SWELLING (Immediate swelling at the injection site after administering) in a 38-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030B21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE SWELLING (Immediate swelling at the injection site after administering). At the time of the report, VACCINATION SITE SWELLING (Immediate swelling at the injection site after administering) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported. No treatment reported.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Computerised tomogram, Contusion, Magnetic resonance imaging, Migraine, Muscle disorder
Clinical narrative: Moderna vaccine triggered a negative reaction causing muscles below the back part of the neck that connect to the back side of the head to cause migraine; Migraine Headache after second vaccine dose; Throat totally inflamed specifically uvula in the back of the throat; Huge purple bruise on his right arm; This spontaneous case was reported by a consumer and describes the occurrence of MIGRAINE (Migraine Headache after second vaccine dose), TRACHEAL INFLAMMATION (Throat totally inflamed specifically uvula in the back of the throat), CONTUSION (Huge purple bruise on his right arm) and MUSCLE DISORDER (Moderna vaccine triggered a negative reaction causing muscles below the back part of the neck that connect to the back side of the head to cause migraine) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030A21A. and 027L20A) for COVID-19 vaccination.     The patient's past medical history included Kidney transplant in July 2016.   On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Mar-2021, the patient experienced MIGRAINE (Migraine Headache after second vaccine dose), TRACHEAL INFLAMMATION (Throat totally inflamed specifically uvula in the back of the throat) and CONTUSION (Huge purple bruise on his right arm). On an unknown date, the patient experienced MUSCLE DISORDER (Moderna vaccine triggered a negative reaction causing muscles below the back part of the neck that connect to the back side of the head to cause migraine). At the time of the report, MIGRAINE (Migraine Headache after second vaccine dose), TRACHEAL INFLAMMATION (Throat totally inflamed specifically uvula in the back of the throat), CONTUSION (Huge purple bruise on his right arm) and MUSCLE DISORDER (Moderna vaccine triggered a negative reaction causing muscles below the back part of the neck that connect to the back side of the head to cause migraine) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Computerised tomogram: unknown (Inconclusive) results not available. On an unknown date, Magnetic resonance imaging: unknown (Inconclusive) results not available. On an unknown date, X-ray: unknown (Inconclusive) results not available.         Action taken with mRNA-1273 in response to the events was  not applicable. Treatment information not provided. List of concomitant medication were not given.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Tracheal inflammation, X-ray
Clinical narrative: Moderna vaccine triggered a negative reaction causing muscles below the back part of the neck that connect to the back side of the head to cause migraine; Migraine Headache after second vaccine dose; Throat totally inflamed specifically uvula in the back of the throat; Huge purple bruise on his right arm; This spontaneous case was reported by a consumer and describes the occurrence of MIGRAINE (Migraine Headache after second vaccine dose), TRACHEAL INFLAMMATION (Throat totally inflamed specifically uvula in the back of the throat), CONTUSION (Huge purple bruise on his right arm) and MUSCLE DISORDER (Moderna vaccine triggered a negative reaction causing muscles below the back part of the neck that connect to the back side of the head to cause migraine) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030A21A. and 027L20A) for COVID-19 vaccination.     The patient's past medical history included Kidney transplant in July 2016.   On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Mar-2021, the patient experienced MIGRAINE (Migraine Headache after second vaccine dose), TRACHEAL INFLAMMATION (Throat totally inflamed specifically uvula in the back of the throat) and CONTUSION (Huge purple bruise on his right arm). On an unknown date, the patient experienced MUSCLE DISORDER (Moderna vaccine triggered a negative reaction causing muscles below the back part of the neck that connect to the back side of the head to cause migraine). At the time of the report, MIGRAINE (Migraine Headache after second vaccine dose), TRACHEAL INFLAMMATION (Throat totally inflamed specifically uvula in the back of the throat), CONTUSION (Huge purple bruise on his right arm) and MUSCLE DISORDER (Moderna vaccine triggered a negative reaction causing muscles below the back part of the neck that connect to the back side of the head to cause migraine) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Computerised tomogram: unknown (Inconclusive) results not available. On an unknown date, Magnetic resonance imaging: unknown (Inconclusive) results not available. On an unknown date, X-ray: unknown (Inconclusive) results not available.         Action taken with mRNA-1273 in response to the events was  not applicable. Treatment information not provided. List of concomitant medication were not given.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Alopecia, Asthenia, Contusion, Dizziness, Erythema
Clinical narrative: lightheaded; weak; increased wheezing; migraines; Hot; Hot flashes; menstrual cycle; noticeable hair loss; sorearm; headache; extreme fatigue; redness with hives and bruising; redness with hives and bruising; covid arm, bump was size of silver coin; redness with hives and bruising; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (lightheaded), ASTHENIA (weak), WHEEZING (increased wheezing), MIGRAINE (migraines) and ERYTHEMA (redness with hives and bruising) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 on 06-Apr-2021. Concurrent medical conditions included Asthma (Increased wheezing) since 1990 and Antiphospholipid syndrome (increased bruising) since 2012. Concomitant products included SERTRALINE HYDROCHLORIDE (ZOLOFT) and TOPIRAMATE for an unknown indication.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced ERYTHEMA (redness with hives and bruising), URTICARIA (redness with hives and bruising), VACCINATION SITE REACTION (covid arm, bump was size of silver coin), CONTUSION (redness with hives and bruising), PAIN IN EXTREMITY (sorearm), HEADACHE (headache) and FATIGUE (extreme fatigue). On an unknown date, the patient experienced DIZZINESS (lightheaded), ASTHENIA (weak), WHEEZING (increased wheezing), MIGRAINE (migraines), ALOPECIA (noticeable hair loss), UNEVALUABLE EVENT (Hot), HOT FLUSH (Hot flashes) and MENSTRUATION IRREGULAR (menstrual cycle). On 18-May-2021, ERYTHEMA (redness with hives and bruising) and CONTUSION (redness with hives and bruising) was resolving. At the time of the report, DIZZINESS (lightheaded), ASTHENIA (weak), WHEEZING (increased wheezing), MIGRAINE (migraines), URTICARIA (redness with hives and bruising), VACCINATION SITE REACTION (covid arm, bump was size of silver coin), PAIN IN EXTREMITY (sorearm), UNEVALUABLE EVENT (Hot), HEADACHE (headache) and FATIGUE (extreme fatigue) outcome was unknown and ALOPECIA (noticeable hair loss), HOT FLUSH (Hot flashes) and MENSTRUATION IRREGULAR (menstrual cycle) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 06-Apr-2021, SARS-CoV-2 antibody test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient ethnic group was Ashkenazic.  No treatment details were reported.  Event outcome was not reported.   This case was linked to INC.-MOD-2021-078037 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 18-May-2021: This Follow-up was received on 18-MAY-2021 which updated patient demographics, historical conditions, lab data, concomitant medications and events.; Sender's Comments: INC.-MOD-2021-078037:cross linked to dose 2
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Hot flush, Menstruation irregular, Migraine
Clinical narrative: lightheaded; weak; increased wheezing; migraines; Hot; Hot flashes; menstrual cycle; noticeable hair loss; sorearm; headache; extreme fatigue; redness with hives and bruising; redness with hives and bruising; covid arm, bump was size of silver coin; redness with hives and bruising; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (lightheaded), ASTHENIA (weak), WHEEZING (increased wheezing), MIGRAINE (migraines) and ERYTHEMA (redness with hives and bruising) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 on 06-Apr-2021. Concurrent medical conditions included Asthma (Increased wheezing) since 1990 and Antiphospholipid syndrome (increased bruising) since 2012. Concomitant products included SERTRALINE HYDROCHLORIDE (ZOLOFT) and TOPIRAMATE for an unknown indication.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced ERYTHEMA (redness with hives and bruising), URTICARIA (redness with hives and bruising), VACCINATION SITE REACTION (covid arm, bump was size of silver coin), CONTUSION (redness with hives and bruising), PAIN IN EXTREMITY (sorearm), HEADACHE (headache) and FATIGUE (extreme fatigue). On an unknown date, the patient experienced DIZZINESS (lightheaded), ASTHENIA (weak), WHEEZING (increased wheezing), MIGRAINE (migraines), ALOPECIA (noticeable hair loss), UNEVALUABLE EVENT (Hot), HOT FLUSH (Hot flashes) and MENSTRUATION IRREGULAR (menstrual cycle). On 18-May-2021, ERYTHEMA (redness with hives and bruising) and CONTUSION (redness with hives and bruising) was resolving. At the time of the report, DIZZINESS (lightheaded), ASTHENIA (weak), WHEEZING (increased wheezing), MIGRAINE (migraines), URTICARIA (redness with hives and bruising), VACCINATION SITE REACTION (covid arm, bump was size of silver coin), PAIN IN EXTREMITY (sorearm), UNEVALUABLE EVENT (Hot), HEADACHE (headache) and FATIGUE (extreme fatigue) outcome was unknown and ALOPECIA (noticeable hair loss), HOT FLUSH (Hot flashes) and MENSTRUATION IRREGULAR (menstrual cycle) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 06-Apr-2021, SARS-CoV-2 antibody test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient ethnic group was Ashkenazic.  No treatment details were reported.  Event outcome was not reported.   This case was linked to INC.-MOD-2021-078037 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 18-May-2021: This Follow-up was received on 18-MAY-2021 which updated patient demographics, historical conditions, lab data, concomitant medications and events.; Sender's Comments: INC.-MOD-2021-078037:cross linked to dose 2
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Wheezing
Clinical narrative: lightheaded; weak; increased wheezing; migraines; Hot; Hot flashes; menstrual cycle; noticeable hair loss; sorearm; headache; extreme fatigue; redness with hives and bruising; redness with hives and bruising; covid arm, bump was size of silver coin; redness with hives and bruising; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (lightheaded), ASTHENIA (weak), WHEEZING (increased wheezing), MIGRAINE (migraines) and ERYTHEMA (redness with hives and bruising) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 on 06-Apr-2021. Concurrent medical conditions included Asthma (Increased wheezing) since 1990 and Antiphospholipid syndrome (increased bruising) since 2012. Concomitant products included SERTRALINE HYDROCHLORIDE (ZOLOFT) and TOPIRAMATE for an unknown indication.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced ERYTHEMA (redness with hives and bruising), URTICARIA (redness with hives and bruising), VACCINATION SITE REACTION (covid arm, bump was size of silver coin), CONTUSION (redness with hives and bruising), PAIN IN EXTREMITY (sorearm), HEADACHE (headache) and FATIGUE (extreme fatigue). On an unknown date, the patient experienced DIZZINESS (lightheaded), ASTHENIA (weak), WHEEZING (increased wheezing), MIGRAINE (migraines), ALOPECIA (noticeable hair loss), UNEVALUABLE EVENT (Hot), HOT FLUSH (Hot flashes) and MENSTRUATION IRREGULAR (menstrual cycle). On 18-May-2021, ERYTHEMA (redness with hives and bruising) and CONTUSION (redness with hives and bruising) was resolving. At the time of the report, DIZZINESS (lightheaded), ASTHENIA (weak), WHEEZING (increased wheezing), MIGRAINE (migraines), URTICARIA (redness with hives and bruising), VACCINATION SITE REACTION (covid arm, bump was size of silver coin), PAIN IN EXTREMITY (sorearm), UNEVALUABLE EVENT (Hot), HEADACHE (headache) and FATIGUE (extreme fatigue) outcome was unknown and ALOPECIA (noticeable hair loss), HOT FLUSH (Hot flashes) and MENSTRUATION IRREGULAR (menstrual cycle) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 06-Apr-2021, SARS-CoV-2 antibody test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient ethnic group was Ashkenazic.  No treatment details were reported.  Event outcome was not reported.   This case was linked to INC.-MOD-2021-078037 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 18-May-2021: This Follow-up was received on 18-MAY-2021 which updated patient demographics, historical conditions, lab data, concomitant medications and events.; Sender's Comments: INC.-MOD-2021-078037:cross linked to dose 2
Sex: U
Vaccine: COVID19
Symptoms: Migraine
Clinical narrative: Mgraine; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an other health care professional and describes the occurrence of MIGRAINE (Mgraine) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MIGRAINE (Mgraine). At the time of the report, MIGRAINE (Mgraine) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided. Treatment medications were unknown.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination.     no specified medical history was reported.  Concomitant products included MULTIVITAMINS [VITAMINS NOS] for an unknown indication.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm). At the time of the report, PAIN IN EXTREMITY (Sore arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information was provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-077987 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-077987:second dose event
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Flushing, Pain in extremity, Peripheral swelling
Clinical narrative: Face flushed after 2nd dose; Face red after 2nd dose; Arm sore after 2nd dose; Arm swollen after 2nd dose; This spontaneous case was reported by a consumer and describes the occurrence of FLUSHING (Face flushed after 2nd dose), ERYTHEMA (Face red after 2nd dose), PAIN IN EXTREMITY (Arm sore after 2nd dose) and PERIPHERAL SWELLING (Arm swollen after 2nd dose) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037a21b and 046b21a) for COVID-19 vaccination.     No medical history was provided by the reporter.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FLUSHING (Face flushed after 2nd dose), ERYTHEMA (Face red after 2nd dose), PAIN IN EXTREMITY (Arm sore after 2nd dose) and PERIPHERAL SWELLING (Arm swollen after 2nd dose). The patient was treated with ACETAMINOPHEN at a dose of UNK dosage form, qd and CAMPHOR, DIPHENHYDRAMINE HYDROCHLORIDE, ZINC OXIDE (BENADRYL [CAMPHOR;DIPHENHYDRAMINE HYDROCHLORIDE;ZINC OXIDE]) at a dose of UNK dosage form, qd. At the time of the report, FLUSHING (Face flushed after 2nd dose), ERYTHEMA (Face red after 2nd dose), PAIN IN EXTREMITY (Arm sore after 2nd dose) and PERIPHERAL SWELLING (Arm swollen after 2nd dose) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported. No treatment reported.   This case was linked to MOD-2021-077946 (E2B Linked Report).; Sender's Comments:  MOD-2021-077946:First dose case
Sex: M
Vaccine: COVID19
Symptoms: Cough, SARS-CoV-2 test positive
Clinical narrative: Little bit cough; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Little bit cough) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Apr-2021, the patient experienced COUGH (Little bit cough). At the time of the report, COUGH (Little bit cough) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 13-Apr-2021, SARS-CoV-2 test positive: Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The patient's medical history was not provided.  No relevant concomitant medications were reported. No treatment information was provided.    This case was linked to US-MODERNATX, INC.-MOD-2021-077934 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.- MOD-2021-077934:case for wife
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: Ringing in ear/ Fuzzy sound; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (Ringing in ear/ Fuzzy sound) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013M20A and 011L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Feb-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced TINNITUS (Ringing in ear/ Fuzzy sound). At the time of the report, TINNITUS (Ringing in ear/ Fuzzy sound) had not resolved. Not Provided          No concomitant medications were reported.  No treatment information was provided.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Sensation of foreign body, Throat tightness
Clinical narrative: felt like she had a lump in her throat; felt like her collar of her shirt was a little tight / in the middle of her throat; This spontaneous case was reported by a consumer and describes the occurrence of SENSATION OF FOREIGN BODY (felt like she had a lump in her throat) and THROAT TIGHTNESS (felt like her collar of her shirt was a little tight / in the middle of her throat) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Mar-2021, the patient experienced SENSATION OF FOREIGN BODY (felt like she had a lump in her throat) and THROAT TIGHTNESS (felt like her collar of her shirt was a little tight / in the middle of her throat). At the time of the report, SENSATION OF FOREIGN BODY (felt like she had a lump in her throat) and THROAT TIGHTNESS (felt like her collar of her shirt was a little tight / in the middle of her throat) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication included vitamins. Events did not interfere with eating or breathing or anything. It went away by the evening/the next day.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Arthritis, Blood pressure increased, Dyspnoea, Headache
Clinical narrative: hot flashes hotter,coldness colder, response to stimuli greater; Anxiety; Forgetfulness; Shortness of breath; Joint Inflammation; Blood pressure increased; Mild headaches; muscle pain; shaky; muscle weakness/ joint weakness; This spontaneous case was reported by a consumer and describes the occurrence of NERVOUSNESS (shaky), MUSCULAR WEAKNESS (muscle weakness/ joint weakness), SENSITIVITY TO WEATHER CHANGE (hot flashes hotter,coldness colder, response to stimuli greater), ANXIETY (Anxiety) and MEMORY IMPAIRMENT (Forgetfulness) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010A21A and 48B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Asthma (shortness of breath) since 2002, Arthritis (increase in joint inflammation and pain), Environmental allergy, Allergic reaction to antibiotics (allergic to doxycycline and bactrim) and Drug allergy (allergic to Prilosec , prometrium). Concomitant products included FLUTICASONE PROPIONATE (FLOVENT) for Asthma, FAMOTIDINE for GERD, VITAMIN D NOS, ASCORBIC ACID (VITAMIN C ACID), ZINC and CALCIUM for an unknown indication.   On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Mar-2021, the patient experienced NERVOUSNESS (shaky), MUSCULAR WEAKNESS (muscle weakness/ joint weakness), HEADACHE (Mild headaches) and MYALGIA (muscle pain). On an unknown date, the patient experienced SENSITIVITY TO WEATHER CHANGE (hot flashes hotter,coldness colder, response to stimuli greater), ANXIETY (Anxiety), MEMORY IMPAIRMENT (Forgetfulness), DYSPNOEA (Shortness of breath), ARTHRITIS (Joint Inflammation) and BLOOD PRESSURE INCREASED (Blood pressure increased). On 05-Mar-2021, NERVOUSNESS (shaky) had resolved. On 18-Mar-2021, HEADACHE (Mild headaches) and MYALGIA (muscle pain) had resolved. At the time of the report, MUSCULAR WEAKNESS (muscle weakness/ joint weakness), SENSITIVITY TO WEATHER CHANGE (hot flashes hotter,coldness colder, response to stimuli greater), ANXIETY (Anxiety), MEMORY IMPAIRMENT (Forgetfulness), DYSPNOEA (Shortness of breath), ARTHRITIS (Joint Inflammation) and BLOOD PRESSURE INCREASED (Blood pressure increased) had not resolved.            Most recent FOLLOW-UP information incorporated above includes: On 26-May-2021: Follow-up received. Patient information , Second dose details , Concomitant medications and events were added
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Memory impairment, Muscular weakness, Myalgia, Nervousness, Sensitivity to weather change
Clinical narrative: hot flashes hotter,coldness colder, response to stimuli greater; Anxiety; Forgetfulness; Shortness of breath; Joint Inflammation; Blood pressure increased; Mild headaches; muscle pain; shaky; muscle weakness/ joint weakness; This spontaneous case was reported by a consumer and describes the occurrence of NERVOUSNESS (shaky), MUSCULAR WEAKNESS (muscle weakness/ joint weakness), SENSITIVITY TO WEATHER CHANGE (hot flashes hotter,coldness colder, response to stimuli greater), ANXIETY (Anxiety) and MEMORY IMPAIRMENT (Forgetfulness) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010A21A and 48B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Asthma (shortness of breath) since 2002, Arthritis (increase in joint inflammation and pain), Environmental allergy, Allergic reaction to antibiotics (allergic to doxycycline and bactrim) and Drug allergy (allergic to Prilosec , prometrium). Concomitant products included FLUTICASONE PROPIONATE (FLOVENT) for Asthma, FAMOTIDINE for GERD, VITAMIN D NOS, ASCORBIC ACID (VITAMIN C ACID), ZINC and CALCIUM for an unknown indication.   On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Mar-2021, the patient experienced NERVOUSNESS (shaky), MUSCULAR WEAKNESS (muscle weakness/ joint weakness), HEADACHE (Mild headaches) and MYALGIA (muscle pain). On an unknown date, the patient experienced SENSITIVITY TO WEATHER CHANGE (hot flashes hotter,coldness colder, response to stimuli greater), ANXIETY (Anxiety), MEMORY IMPAIRMENT (Forgetfulness), DYSPNOEA (Shortness of breath), ARTHRITIS (Joint Inflammation) and BLOOD PRESSURE INCREASED (Blood pressure increased). On 05-Mar-2021, NERVOUSNESS (shaky) had resolved. On 18-Mar-2021, HEADACHE (Mild headaches) and MYALGIA (muscle pain) had resolved. At the time of the report, MUSCULAR WEAKNESS (muscle weakness/ joint weakness), SENSITIVITY TO WEATHER CHANGE (hot flashes hotter,coldness colder, response to stimuli greater), ANXIETY (Anxiety), MEMORY IMPAIRMENT (Forgetfulness), DYSPNOEA (Shortness of breath), ARTHRITIS (Joint Inflammation) and BLOOD PRESSURE INCREASED (Blood pressure increased) had not resolved.            Most recent FOLLOW-UP information incorporated above includes: On 26-May-2021: Follow-up received. Patient information , Second dose details , Concomitant medications and events were added
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Dyspnoea, Hypoaesthesia, Skin tightness
Clinical narrative: Dizziness/lightheadedness; Numbness and tightness in face; Numbness and tightness in face; Shortness of breath; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness/lightheadedness), HYPOAESTHESIA (Numbness and tightness in face), SKIN TIGHTNESS (Numbness and tightness in face) and DYSPNOEA (Shortness of breath) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006B21A) for COVID-19 vaccination.     Concomitant products included CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY), INSULIN GLARGINE (LANTUS), INSULIN LISPRO (HUMALOG) and BUPROPION HYDROCHLORIDE (WELLBUTRIN) for an unknown indication.    On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Apr-2021, the patient experienced DIZZINESS (Dizziness/lightheadedness), HYPOAESTHESIA (Numbness and tightness in face), SKIN TIGHTNESS (Numbness and tightness in face) and DYSPNOEA (Shortness of breath). On 13-Apr-2021, DYSPNOEA (Shortness of breath) had resolved. At the time of the report, DIZZINESS (Dizziness/lightheadedness), HYPOAESTHESIA (Numbness and tightness in face) and SKIN TIGHTNESS (Numbness and tightness in face) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information was not provided.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Depression, Headache, Lymphadenopathy
Clinical narrative: Depression got bad; Swelling in lymph nodes on both sides; Headache; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of DEPRESSION (Depression got bad), LYMPHADENOPATHY (Swelling in lymph nodes on both sides) and HEADACHE (Headache) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Depression, Hypertension and Osteoporosis. Concomitant products included ESCITALOPRAM OXALATE (LEXAPRO) for Depression, LISINOPRIL for Hypertension, CALCIUM CARBONATE, COLECALCIFEROL (CALCI NET D3) for Osteoporosis, FEXOFENADINE HYDROCHLORIDE (ALLEGRA), CELECOXIB (ZOBREX), MONTELUKAST SODIUM (SINGULAIR) and MACROGOL 3350 (MIRALAX) for an unknown indication.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DEPRESSION (Depression got bad), LYMPHADENOPATHY (Swelling in lymph nodes on both sides) and HEADACHE (Headache). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, DEPRESSION (Depression got bad), LYMPHADENOPATHY (Swelling in lymph nodes on both sides) and HEADACHE (Headache) outcome was unknown. Not Provided          Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.    This case was linked to US-MODERNATX, INC.-MOD-2021-049893 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-049893:
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Pain in extremity
Clinical narrative: swollen lymph node under arm pit. (left arm); Pain in arm (left arm); This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (swollen lymph node under arm pit. (left arm)) and PAIN IN EXTREMITY (Pain in arm (left arm)) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Implant) 1 dosage form. On 26-Mar-2021, the patient experienced LYMPHADENOPATHY (swollen lymph node under arm pit. (left arm)) and PAIN IN EXTREMITY (Pain in arm (left arm)). The patient was treated with IBUPROFEN (ADVIL 12 HOUR) at an unspecified dose and frequency. At the time of the report, LYMPHADENOPATHY (swollen lymph node under arm pit. (left arm)) and PAIN IN EXTREMITY (Pain in arm (left arm)) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Implant) was unknown.       Treatment information included Advil.   This case was linked to US-MODERNATX, INC.-MOD-2021-077735, US-MODERNATX, INC.-MOD-2021-077745, US-MODERNATX, INC.-MOD-2021-077940 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-077735: US-MODERNATX, INC.-MOD-2021-077745: US-MODERNATX, INC.-MOD-2021-077940:
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during pregnancy, Pain in extremity, Pregnancy test
Clinical narrative: sore arm; pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) and MATERNAL EXPOSURE DURING PREGNANCY (pregnancy) in a 31-year-old female patient (gravida 2) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025B21A) for COVID-19 vaccination.     The patient's past medical history included Obsession in 2011 and Clotting disorder in 2008. Concurrent medical conditions included Penicillin allergy and Alcohol use (couple beers/week). Concomitant products included FLUOXETINE HYDROCHLORIDE (PROZAC) and PRENATAL VITAMINS [ASCORBIC ACID;BETACAROTENE;CALCIUM SULFATE;COLECALCIFEROL;CYANOCOBALAMIN;FERROUS FUMARATE;FOLIC ACID;NICOTINAMIDE;PYRIDOXINE HYDROCHLORIDE;RETINOL ACETATE;RIBOFLAVIN;THIAMINE MONONITRATE;TOCOPHERYL ACETATE;ZINC OXIDE] for an unknown indication.    On 10-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 21-Aug-2020 and the estimated date of delivery was 26-May-2021. On 10-Apr-2021, the patient experienced PAIN IN EXTREMITY (sore arm) and MATERNAL EXPOSURE DURING PREGNANCY (pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  thirty-third week of the pregnancy.  On 10-Apr-2021, MATERNAL EXPOSURE DURING PREGNANCY (pregnancy) had resolved. On 12-Apr-2021, PAIN IN EXTREMITY (sore arm) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Sep-2020, Pregnancy test: positive (Positive) positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment details not included. Patient's previous pregnancy end date was on 30 May 2014 and outcome was Induced abortion.
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site irritation
Clinical narrative: irritation in left arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE IRRITATION (irritation in left arm) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     Concomitant products included LISINOPRIL, GABAPENTIN, ALPRAZOLAM, ASPIRIN [ACETYLSALICYLIC ACID], VITAMIN D3, CHONDROITIN SULFATE SODIUM, COLECALCIFEROL, GLUCOSAMINE SULFATE POTASSIUM CHLORIDE (GLUCOSAMINE CHONDROITIN WITH VITAMIN D3 EXTRA STRENGTH PREMIUM FORMULA) and DICLOFENAC for an unknown indication.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In March 2021, the patient experienced VACCINATION SITE IRRITATION (irritation in left arm). At the time of the report, VACCINATION SITE IRRITATION (irritation in left arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment information was not provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-077942 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-077942:2 nd dose
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Malaise, Nasal congestion, Sneezing
Clinical narrative: Sneezing; Coughing; Nasal congestion; Felt Effie; This spontaneous case was reported by a consumer and describes the occurrence of SNEEZING (Sneezing), COUGH (Coughing), NASAL CONGESTION (Nasal congestion) and MALAISE (Felt Effie) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A) for COVID-19 vaccination.     Concurrent medical conditions included Seasonal allergy and Pollen allergy.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, the patient experienced MALAISE (Felt Effie). On 15-Apr-2021, the patient experienced SNEEZING (Sneezing), COUGH (Coughing) and NASAL CONGESTION (Nasal congestion). On 22-Mar-2021, MALAISE (Felt Effie) had resolved. At the time of the report, SNEEZING (Sneezing), COUGH (Coughing) and NASAL CONGESTION (Nasal congestion) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 17-May-2021: Non significant follow up received on 17-MAY-2021, no new information